GENSIGHT BIOLOGICS: 6 month CMC delay materialises; reduce TP keep rating | BUY | EUR13 VS. EUR16 (+100%)
GENSIGHT BIOLOGICS - BUY | EUR13 VS. EUR16 (+100%)6 month CMC delay materialises; reduce TP keep rating
CMC issues still correlated to earlier delay…
… EMA/FDA timeline slips into 4Q
Reduce TP to EUR13 (from EUR16) retain BUY
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.